Skip to search formSkip to main contentSkip to account menu

spinorphin

Known as: L-Threonine, N-(N-(1-(N-(N-(N-L-leucyl-L-valyl)-L-valyl)-L-tyrosyl)-L-prolyl)-L-tryptophyl)-, Leu-Val-Val-Tyr-Pro-Trp-Thr, leucyl--valyl-valyl-tyrosyl-prolyl-tryptophyl-threonine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Objective: Spinorphin is a potential endogenous antinociceptive agent although the mechanism(s) of its analgesic effect… 
2014
2014
Obesity is a worldwide epidemic and has become a public health priority for which there is a need for effective treatments. It is… 
2007
2007
Spinorphin, an endogenous antinociceptive peptide (LVVYPWT), showed potent and non-competitive antagonism at the ATP-activated… 
2003
2003
BACKGROUND In the course of elucidating physiological roles of spinorphin, an endogenous regulator of enkephalin-degrading enzyme… 
2000
2000
We have found activity of dipeptidyl peptidase (DPP) III, one of the most important enkephalin-degrading enzymes in the central… 
1993
1993
Spinorphin, a potent inhibitor of enkephalin degrading enzyme isolated from the bovine spinal cord, produces a dose-related…